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Abstract P2X receptors are ATP-gated cation channels
and assembled as homotrimers or heterotrimers from seven
cloned subunits. Each subunit contains two transmembrane
domains connected by a large extracellular loop. We have
previously shown that replacement of two conserved resi-
dues, K68 and F291, by cysteine residues leads to disulWde
cross-linking between neighbouring P2X1 subunits. Since
mutation of these residues results in a reduced ATP potency
and cysteine cross-linking is prevented in the presence of
ATP, we suggested an inter-subunit ATP binding site. To
investigate whether the proximity of these residues is pre-
served in other P2X subtypes, we tested for spontaneous
cystine formation between the corresponding P2X2 (K69C,
F289C), P2X3 (K63C, F280C), and P2X4 (K67C, F294C)
mutants upon pairwise expression in Xenopus laevis
oocytes. Non-reducing SDS-PAGE analysis of the puriWed
receptors revealed a speciWc dimer formation between
P2X2K69C and P2X2F289C mutants. Likewise, co-expres-
sion of P2X1K68C and P2X2F289C, but not P2X1F291C
and P2X2K69C, mutants resulted in dimer formation
between the respective subunits. Cross-linked P2X1/2 heter-
omers showed strongly reduced or absent function that was
selectively recovered upon treatment with DTT. Cross-
linking was less eYcient between P2X3 or P2X4 mutants
but could be enhanced by the short cysteine-reactive cross-
linker MTS-2-MTS. These results show that the spatial
proximity and/or orientation of residues analogous to posi-
tions K68 and F291 in P2X1 are preserved in P2X2 recep-
tors and at one of two possible interfaces in heteromeric
P2X1/2 receptors but appears to be redundant for P2X3 and
P2X4 receptor function.
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Extracellular ATP is an autocrine and paracrine messenger
molecule as well as a neurotransmitter. P2X receptors
(P2XRs) are ATP-activated non-selective cation channels
with a high Ca2+ permeability. Besides cys-loop receptors
[comprising nicotinic acetylcholine receptors (nAChRs),
serotonine receptor subtype 3, glycine receptors, and
GABAA and GABAC receptors] and ionotropic glutamate
receptors (iGluRs, comprising AMPA, kainate and NMDA
receptors), P2XRs represent a third major family of neuro-
transmitter-gated ion channels. For both the tetrameric
iGluR and the pentameric nAChR families the molecular
structure of their agonist binding sites has been obtained by
the X-ray structural analysis of soluble proteins with high
homology to the respective agonist binding sites.
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330 Eur Biophys J (2009) 38:329–338The subunits of the cys-loop receptor family contain a
large extracellular N-terminus followed by four transmem-
brane domains (TM1–TM4) with a large intracellular loop
between TM3 and TM4. A molluscan ACh-binding protein
resembles the extracellular N-terminal domain of the
nAChR and other members of the cys-loop receptor family
and likewise forms pentamers. Its crystal structure con-
Wrmed that the agonist binding pocket of this receptor fam-
ily is formed at the interface of two neighbouring subunits
by three loop-like structures from the principal (-) subunit
(A–C) and three -strands from the complementary (-)
subunit (D–F) (Brejc et al. 2001). The principal (+) face of
both the nAChR and AChBP binding pocket contributes
Wve conserved aromatic side chains, a backbone carbonyl
oxygen and a vicinal disulWde bridge located at the tip of
the Xexible loop C. The complementary (¡) face is formed
by more variable, mostly hydrophobic side chains. The
Xexible loop C is covering this binding pocket, and a clos-
ing movement of this loop upon agonist binding is assumed
to initiate the conformational rearrangements that lead to
channel opening (Hansen et al. 2005).
Subunits of the tetrameric ionotropic GluR family show
a characteristic modular organization including an amino-
terminal domain (ATD), three transmembrane domains
(M1, M3 and M4), a re-entry loop (M2) which lines the
lumen of the ion channel, and an intracellular carboxy-ter-
minal domain. The agonist-binding sites of both metabotro-
pic and ionotropic glutamate receptors show homology to
bacterial periplasmic amino acid binding proteins. Using
these as a template for the design of soluble iGluR ligand-
binding domains, crystal structures for multiple “receptor”–
ligand complexes were obtained (for reviews see Mayer
2006; Gouaux 2004). In contrast to the agonist binding sites
of the cys-loop receptor family, the glutamate binding site
of the ionotropic GluR is located within a single subunit
between two separate extracellular segments, S1 (between
TM1 and ATD) and S2 (between TM3 and TM4). The two
segments are supposed to close in a “venus-Xytrap”- or
“clam-shell”-like mechanism upon agonist binding, thereby
initiating the conformational changes necessary for channel
opening. An arginine side chain (on helix D in S1) is essen-
tial for the high aYnity binding of the -carboxyl group of
the ligand while the -amino group of the ligand is bound
by a conserved acidic side chain (on a loop prior to helix I
on S2). iGluR subtypes diVer in the number of water mole-
cules necessary for coordinating the ligand, which is reX-
ected in the variable size of the ligand binding pocket
(Mayer 2005, 2006; Gouaux 2004).
A single P2X subunit contains two transmembrane
domains linked by a large extracellular loop (North 2002),
and a functional P2X receptor has been shown to consist
of three subunits (Nicke et al. 1998; Barrera et al. 2005).
An additional structural feature is ten conserved cysteine
residues in the extracellular loop, which are arranged in two
domains from C117 to C165 (six cysteine residues) and
from C217 to C270 (four residues), respectively (P2X1
sequence numbering). There is evidence that most, if not all
ten cysteine residues form disulWde bridges within these
domains (Clyne et al. 2002; Ennion and Evans 2002). Very
recently, crystallization of the acid sensing ion channel 1
subtype (ASIC1), a member of the degenerin and epithelial
sodium channel family, also revealed a trimeric structure
(Jasti et al. 2007). Besides their quaternary structure, these
ion channels share a common membrane topology with the
P2XRs and likewise show a highly conserved but distinct
arrangement of cysteine residues. However, the absence of
a common cysteine pattern or conserved amino acid motifs
between these ion channel families makes homology mod-
elling of P2X receptors unlikely. Since no protein with
sequence homology to P2X receptors has been identiWed,
the information about its agonist-binding site is mainly
based on mutagenesis studies.
Based on a model derived from secondary structure pre-
dictions, it has been proposed that the second half of the
extracellular loop is folded similar to aminoacyl t-RNA
synthetases (Freist et al. 1998) and harbours the ATP bind-
ing site. This hypothesis is supported by a mutagenesis
study on P2X4 receptors (Yan et al. 2005). Alanine substi-
tution of conserved positively charged amino acid residues
identiWed three lysine residues (K68, K70, and K309 in
P2X1) that are important for a high ATP potency in P2X1
and P2X2 receptors and were suggested to interact with the
negatively charged phosphate chain of the ATP molecule
(Ennion et al. 2000; Jiang et al. 2000). These results have
partly been conWrmed at P2X3, P2X4, and P2X7 receptors
(Wilkinson et al. 2006; Zemkova et al. 2007; Worthington
et al. 2002). A recent single channel analysis on the back-
ground of a spontaneously opening P2X2 mutant provides
good evidence that at least K68 contributes directly to ATP
binding while residues corresponding to K309 are more
likely to have a function in channel gating (Cao et al.
2007). In addition, a conserved arginine residue (R292) and
conserved aromatic amino acid residues (F185, F291), in
particular, the conserved NFR motif (N290-R292 in P2X1)
has been supposed to contribute to ATP binding, possibly
by interacting with the adenine ring (Roberts and Evans
2004, 2007). We have shown before that K68 and F291 of
neighbouring P2X1 subunits are in close proximity (Mar-
quez-Klaka et al. 2007), suggesting an intersubunit binding
site, similar as in nAChRs. This conclusion is supported by
a functional study suggesting that K69 (corresponding to
K68 in P2X1) and K308 from neighbouring P2X2 subunits
contribute to ATP binding (Wilkinson et al. 2006).
To date, seven mammalian P2X subtypes have been
cloned (P2X1–7). Like in other ion channel families, func-
tional and pharmacological diversity of P2X receptors is123
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assumed that the arrangement of residues critical for recep-
tor function is preserved in diVerent channel subtypes. In
this study, we used site-directed disulWde cross-linking to
investigate whether the close proximity between residues
homologous to K68 and F291 in P2X1 is preserved in other
P2X subtypes.
Materials and methods
cDNA constructs and cRNA synthesis
Construction of N-terminal hexahistidyl-tagged rat P2X1
(His-P2X1) cDNAs in the pNKS2 oocyte expression vector
has been described previously (Nicke et al. 1998). Rat
P2X2, P2X3 and P2X4 clones were friendly provided by Dr.
F. Soto (MPI for Experimental Medicine, Göttingen). The
respective sequences were N-terminally His-tagged by
PCR and subcloned into pNKS2, in an identical context as
the His-P2X1 sequence.
Site-directed mutagenesis was performed with the
QuickChange mutagenesis Kit (Stratagene, La Jolla, CA,
USA). Primers for cloning and mutagenesis were synthe-
sized by MWG Biotech AG (Ebersberg, Germany).
Sequences of all the constructs were veriWed by dide-
soxynucleotide sequencing (MWG Biotech AG). Capped
cRNA was synthesized from linearized templates with SP6
RNA polymerase using the Message Machine kit (Ambion,
Austin, TX, USA).
Protein biochemistry
Xenopus laevis toads were obtained from Nasco Interna-
tional (Fort Atkinson, WI, USA). Oocytes were prepared
as previously described (Nicke et al. 1998) and, if not
otherwise noted, injected with 50 nl aliquots of cRNA
(0.5 g/l). To obtain similar amounts of surface labelled
protein and to optimize the cross-link eYciency, cRNA
ratios were adjusted to account for the diVerent expression
levels of the mutants. cRNA-injected oocytes and non-
injected control cells were metabolically labelled by over-
night incubation at 19°C with L-[35S]-methionine at
»100 MBq/ml with »0.1 MBq/oocyte (Perkin Elmer Life
and Analytical Sciences, Rodgau-Jügesheim, Germany) in
sterile ND96 (96 mM NaCl, 2 mM KCl, 1 mM CaCl2,
1 mM MgCl2 and 5 mM HEPES, pH 7.4) supplemented
with gentamycin (50 g/ml, Sigma, Taufkirchen, Ger-
many), and subsequently kept for 48 h in 10 mM un-
labelled methionine in ND96. For speciWc labelling of
plasma membrane proteins, intact oocytes were incubated
for 30 min in 50 lM Cy5-NHS-ester (GE Healthcare,
Munich, Germany) in sterile ND96 (pH 8.5) 3 days after
injection. Cysteine-speciWc cross-linking was carried out
prior to surface labelling by a 10 min incubation in
100 lM 1,2-ethanediyl-bismethanethiosulfonate (MTS-2-
MTS, Toronto Research Chemicals, North York, Canada)
in ND96 (pH 8.5). To obtain comparable amounts of
membrane bound receptors, expression times of the
mutants were adapted. Oocytes were subsequently
extracted as described previously (Marquez-Klaka et al.
2007), except that 50 mM iodoacetamide (Sigma, Tauf-
kirchen, Germany) were added to the solubilization
buVer, and 10 mM iodoacetamide to the washing buVer,
to reduce unspeciWc cross-linking.
Blue native PAGE and SDS-PAGE were carried out as
described (Schägger et al. 1994; Nicke et al. 1998; Mar-
quez-Klaka et al. 2007). To account for variations in the
amount of loaded protein, protein bands were quantiWed,
and the amount of dimer was expressed as percentage of the
total amount of P2X protein [monomer, dimer and (if pres-
ent) trimer bands]. Gel documentation, analysis and band
quantiWcation were done on a Typhoon Trio Fluorescence
Scanner (GE Healthcare, Munich, Germany) using the
ImageQuant software (GE Healthcare, Munich, Germany).
Experiments were repeated at least three times and similar
results were obtained. Data are presented as mean § SE.
Electrophysiological recordings
Current responses to ATP were measured 1–3 days after
cRNA injection into X. laevis oocytes by using the two-
electrode voltage-clamp technique. The standard solution
used to superfuse the oocytes contained 90 mM NaCl,
1 mM KCl, 2 mM MgCl2, and 5 mM HEPES, pH 7.4
(Mg2+ Oocyte Ringer). Calcium salts were omitted to
avoid activation of endogenous Ca2+-activated Cl¡ chan-
nels upon opening of P2X receptors by 300 M ATP
(Sigma, Taufkirchen, Germany). Glass microelectrodes
were Wlled with 3 M KCl solution and had resistances
below 1 M. Two Ag/AgCl bath electrodes were used to
minimize series resistance errors. Currents were recorded
at a holding potential of ¡60 mV using a TEC-03 or a
TEC-05 ampliWer (npi electronics, Lambrecht, Ger-
many), low pass Wltered at 100 Hz and sampled at
200 Hz. A fast and reproducible solution exchange
between diVerent solutions was achieved by using a
»50 l recording chamber continuously perfused at a
rate of »10 ml/min (Rettinger and Schmalzing 2003).
Solutions were switched by magnetic valves under the
control of Cellworks software (npi electronics, Lambr-
echt, Germany). All the measurements were carried out
at room temperature (20¡22°C). Data analysis was
performed with Origin 7.5 software (OriginLab Corp.,
Northampton, MA, USA). Data are presented as mean §
SE from N experiments.123
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Using a disulWde cross-linking approach, we have previ-
ously found that co-expression of the P2X1K68C and
P2X1F291C mutant subunits in X. laevis oocytes leads to a
spontaneous and speciWc dimer formation between the
respective subunits (Marquez-Klaka et al. 2007). Likewise,
expression of double mutant P2X1K68C/F291C subunits
leads to the formation of cross-linked trimers. K68 and
F291 have been supposed to contribute to ATP binding and
in agreement with this, cysteine cross-linking between co-
expressed single mutant subunits and double mutant sub-
units was speciWcally prevented in the presence of ATP.
Based on these Wndings, we have suggested that the ATP
binding site is formed at the interface of two neighbouring
subunits similar as in the nAChR family members. To test
whether the analogous residues have a similar distance and
orientation in other P2X subunits, we substituted the corre-
sponding residues in hexahistidyl-tagged rat P2X2 (K69,
F289), P2X3 (K63, F280) and P2X4 (K67, F294) subunits
by cysteine residues. In addition to the ten conserved cyste-
ine residues in their extracellular loop (Clyne et al. 2002;
Ennion and Evans 2002), P2X2Rs, P2X3Rs, and P2X4Rs
contain three, two, and four cysteine residues, respectively
in their intracellular termini. Upon expression of these
mutants in X. laevis oocytes, the P2X receptor complexes
were puriWed under non-denaturing conditions via Ni2+-
NTA agarose and analysed by non-reducing SDS-PAGE
analysis. To avoid unspeciWc multimerization and aggrega-
tion during puriWcation or electrophoresis, iodacetamide
was included throughout the protein puriWcation. To ensure
that only correctly folded, mature and functional P2X pro-
tein was visualized, we selectively labelled plasma mem-
brane proteins by NHS-conjugated Cy5. Thus exclusively
surface receptors were detected.
Cross-linking between P2X2K69C and P2X2F289C
Sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) analysis of co-expressed P2X2K69C
and P2X2F289C mutants under non-reducing conditions
showed a spontaneous and speciWc formation of a band cor-
responding in size to a dimer (Fig. 1a, lane 4). Quantitative
analysis revealed that the cross-linked fraction corre-
sponded to 28.5 § 3.7% of the total surface-labelled P2X
protein. SigniWcantly less (<5%) dimer formation was visi-
ble for non-mutated P2X2 subunits and separately
expressed single mutant P2X2 subunits (Fig. 1a, lanes 1–3).
As previously observed with the corresponding P2X1
mutants, the respective double mutant P2X2K69C/F289C
subunit was eYciently cross-linked into trimers (Fig. 1a,
lane 5). Unlike what we have seen previously with the dou-
ble mutant P2X1 receptors (Marquez-Klaka et al. 2007), a
strong monomeric band (50.6 § 0.2% of the total P2X pro-
tein) of the P2X2K69C/F289C subunits remained, indicat-
ing that the cross-linking was less eVective than in P2X1Rs.
A faint additional band corresponding in size to a tetramer
has also been observed previously and most likely repre-
sents an incompletely cross-linked trimer (Nagaya et al.
2005; Marquez-Klaka et al. 2007). In support of this inter-
pretation, only complexes corresponding to trimers were
detected by BN-PAGE analysis of metabolically labelled
P2X1 complexes (Marquez-Klaka et al. 2007) and P2X2
complexes (not shown). Therefore we excluded that cross-
linking was an artefact resulting from aggregation during
the puriWcation process.
Cross-linking between P2X3K63C and P2X3F280C 
and cross-linking between P2X4K67C and P2X4F294C
Co-expression of P2X3K63C and P2X3F280C single
mutants did not lead to a signiWcant increase in dimer
formation (5.6 § 0.7%) as compared to the separately
expressed single mutants 4.6 § 0.6 and 4.0 § 0.9% for
P2X3K63C and P2X3F280C, respectively (Fig. 1b, lanes
1-3). Likewise, the propensity of P2X4K67C and
P2X4F294C single mutants to dimerize (7.8 § 2.8 and
7.9 § 3.0%, respectively) was not markedly increased
upon co-expression (11.9 § 1.7%, Fig. 1c, lanes 1-3). The
slightly higher background in the P2X4 mutants is likely
due to the higher number of endogenous cysteine residues.
These Wndings suggest that the orientation and/or distance
of the critical lysine and phenylalanine residues clearly
diVer between P2X receptor subtypes. While a close prox-
imity between these residues seems to be preserved in
monomeric P2X1 and P2X2 receptors they seem to be more
remote in P2X3 and P2X4 receptors. In an attempt to esti-
mate the distance between these residues in P2X3 and
P2X4 receptors we applied the homobifunctional cysteine-
reactive cross-linker MTS-2-MTS (spacer length 5.2 Å,
Loo and Clarke 2001). Treatment of oocytes with 0.1 mM
MTS-2-MTS increased the dimer fraction to 22.3 § 2.1%
in case of the co-expressed P2X3 mutants (K63C + F280C)
while the background of dimer fraction in the single
mutants was not markedly increased (4.3 § 0.5% without
cross-linker to 5.0 § 0.3% with cross-linker, Fig. 1b lanes
4-6). For co-expressed P2X4K67C and P2X4F294C
mutants, the dimer band intensity increased to 25.0 § 0.5%
(with cross-linker) in comparison to the single mutant
dimer fractions of 7.8 § 1.7% (without cross-linker) and
9.4 § 0.5% (with cross-linker, Fig. 1c, lanes 4-6). The
longer cross-linker MTS-4-MTS was also tested but
unspeciWcally increased the dimer fraction also in the sin-
gle mutants (not shown). In conclusion, a cysteine-speciWc
cross-linking of mutated subunits was achieved with the
short cross-linker MTS-2-MTS although the eYciency was123
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and P2X2 mutants.
Heteromerization of P2X1 and P2X2 subunits
The spontaneous dimerization of P2X2K69C and
P2X2F289C single mutants which proceeds with similar
eYciency as cross-linking between P2X1K68C and
P2X1F291C single mutants, prompted us to investigate
heteromerization between P2X1 and P2X2 subunits by
co-expressing P2X1K68C with P2X2F289C single mutants
and vice versa (Fig. 2a). Co-expression of P2X1K68C with
P2X2F289C resulted in the formation of a dimer band of
intermediate size (about 120 kDa, Fig. 2a lane 2), between
the P2X1K68C + P2X1F291C dimer (100 kDa, Fig. 2a, lane
6) and the P2X2K69C + P2X2F289C dimer (135 kDa,
Fig. 2a, lane 1). The relative amount of the heteromeric
P2X1K68C + P2X2F289C dimer was 12.5 § 0.2% of the
total protein in comparison to background levels of
2.9 § 0.2 and 2.9 § 0.3% dimer formation for the negative
controls P2X1K68C + P2X2K69C and P2X1F291C +
P2X2F289C, respectively (Fig. 2a, lanes 3 and 5). The latter
combinations should not be capable of forming a dimer by
intersubunit disulWde cross-linking (Fig. 2b, schemes 3 and
5) in contrast to the P2X1K68C + P2X2F289C and
P2X1F291C + P2X2K69C combinations (Fig. 2b, schemes
2 and 4). Interestingly, no signiWcant dimerization occurred
upon co-expression of P2X1F291C and P2X2K69C mutants
(4.1 § 1.1% dimer fraction), suggesting that P2X1 and
P2X2 are able to heteromerize but that the interfaces
between the adjoining subunits are not equivalent (Fig. 2a;
lane 4, Fig. 2b).
Fig. 1 Non-reducing SDS-PAGE analysis of separately and co-
expressed His-P2X2 (a), His-P2X3 (b) and His-P2X4 (c) mutants in
which K68 and F291 residues (P2X1 numbering) were substituted by
cysteine residues. Intact Xenopus laevis oocytes injected with the indi-
cated cRNAs and non-injected control oocytes (Control) were surface
labelled by incubation in Cy5-sulfo-NHS 3 days after injection and
His-tagged proteins were puriWed via Ni2+-NTA agarose. In case of
cross-linking with the cysteine-speciWc cross-linker MTS-2-MTS,
cells were additionally incubated in MTS-2-MTS prior to puriWcation.
d Graphic representation of the maximal possible fraction of cross-
linked dimer (as fraction of total P2X protein) depending on the
eVective ratio of the two mutant subunits. The maximally possible
fraction of dimer was calculated assuming a binomial distribution of
two mutant subunits in heterotrimeric receptors. Parameters like
temporal or spatial diVerences in expression and plasma membrane
transport of subunits are neglected. A purely stochastic assembly (and
no preferential stoichiometry) and 100% complete cystine formation
are assumed123
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Two-electrode voltage-clamp analysis of P2X1Rs contain-
ing the K68C/F291C double mutation has shown that the
disulWde cross-linked receptors are non-functional but can
be rendered functional after reduction of the disulWde bond
by DTT (Marquez-Klaka et al. 2007). Hence, the two cyste-
ine substitutions do not prevent ATP binding and receptor
activation unless they are forming a disulWde bond. There-
fore, speciWc activation of cross-linked P2X1/2 heteromers
should be possible. To functionally investigate heteromer-
ization between P2X1K68C and P2X2F289C subunits, two-
electrode voltage-clamp analysis of receptor currents was
performed in Xenopus oocytes. Individual expression of
P2X1K68C or P2X2F289C subunits gave rise to the sub-
type-characteristic desensitizing or non-desensitizing cur-
rents, respectively (Fig. 3a, c). The desensitization time
course of the P2X1K68C receptor currents was biphasic and
not signiWcantly altered by DTT treatment. It could be
described by the sum of two exponential functions of about
equal amplitude (see Table 1). Co-expression of both
mutated subunits by injection of P2X1K68C and
P2X2F289C cRNA in equal amounts resulted in purely non-
desensitizing currents (data not shown), most likely repre-
senting P2X2F289C homomers. An additional desensitizing
component resembling the P2X1K68C homomer appeared
only if P2X1K68C and P2X2F289C cRNAs were injected in
a ratio larger than 6:1. This suggests that at P2X1K68C/
P2X2F289C ratios below 6:1, the P2X1K68C subunits co-
assemble almost quantitatively with P2X2F289C subunits to
form heteromeric receptors. These heteromers could be
either non-functional due to cross-linking or functional but
resembling the non-desensitizing P2X2F289C phenotype.
Fig. 2 Heteromerization and cross-linking between cysteine-
substituted P2X1 and P2X2 subunits. a Non-reducing SDS-PAGE anal-
ysis of surface labelled P2X1K68C, P2X1F291C, P2X2K69C, and
P2X2F289C mutants that were co-expressed in pair wise combinations.
For clarity, cysteine-substituted lysine and phenylalanine residues are
indicated as K and F, respectively. Coloured arrows indicate the
dissociated monomeric P2X1 and P2X2 subunits. b Schematic
representation of mutant heteromers and expected locations of the
mutations in the co-expression experiment. Grey shaded subunits
indicate either one of the co-expressed subunits, blue and red circles
indicate cysteine-substituted lysine and phenylalanine residues,
respectively and numbers correspond to lanes in (a). The dotted line
indicates the non-cross-linked interface. Note that the respective
homomeric complexes are not presented in the scheme
Fig. 3 Functional characterization of homomeric P2X1K68C and
P2X2F289C and heteromeric P2X1K68C/P2X2F289C receptors. The
left panel shows original current recordings from individual oocytes
injected with cRNA encoding P2X1K68C (a), P2X2F289C (c) or both
mutants (e) without (smaller current amplitude) and after (larger cur-
rent amplitude) a 15 min pre-incubation in solution containing 10 mM
DTT. The right panel (b, d, and f) shows the corresponding current
amplitudes normalized to the currents before DTT treatment
(mean § SE, N = 5–7, * signiWcance at P < 0.01 level, ** signiWcance at
P < 0.001 level). For b and d, total peak currents were used for analy-
sis, while only the desensitizing component of the total current was
used for analysis in f. The dashed line indicates the current level that
would be expected after DTT treatment if the desensitizing part of
receptor current before DTT treatment would originate from mono-
meric P2X1K68C receptors alone123
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injected P2X1K68C and P2X2F289C cRNA in the 6:1 ratio
where a desensitizing component mediated by P2X1K68C
homomers was virtually absent and compared currents in
response to 300 M ATP with and without a 15 min pre-
incubation in 10 mM DTT. Without DTT-treatment, only
0.33 § 0.29 A of the total current was desensitizing
(Fig. 3e, f). After DTT-treatment the desensitizing compo-
nent increased more than 10-fold to 4.0 § 0.69 A. Again,
the desensitization time course had biphasic kinetics with
slightly smaller time constants as compared to homomeric
P2X1K68C receptor desensitization (see Table 1). In com-
parison, the desensitizing homomeric P2X1K68C receptor
current was increased only 2.4-fold after DTT treatment
(Fig. 3a, b), while the homomeric P2X2F289C receptors
remained non-desensitizing after DTT-treatment and only
slightly increased in amplitude (Fig. 3c, d). Therefore, the
newly appearing desensitizing component most probably
represents heteromeric receptors that were rendered func-
tional after reduction of the intersubunit disulWde bridge.
Further functional characterization of the P2X1/2 heteromer
was hampered by the reduced ATP potency at the presumed
binding site mutants. Marked cross-linking in heteromeric
combinations containing P2X3 or P2X4 mutants was not
oberved, most probably because of the poor propensity of
these mutants to form inter-subunit cross-links.
Discussion
The conserved K68 and F291 residues (P2X1 numbering)
have been presumed to contribute to ATP binding in
P2XRs, and we have previously shown that substitution of
these residues by cysteine residues leads to a spontaneous
and eYcient disulWde cross-link between neighbouring
P2X1 subunits. Here, we substituted the corresponding
lysine and phenylalanine residues in P2X2 (K69, F289),
P2X3 (K63, F280) and P2X4 (K67, F294) subunits by cyste-
ine residues to examine whether the close proximity
between these residues is preserved in other P2X receptor
subtypes. We Wnd similar results as for P2X1Rs with the
mutated P2X2 subunits. Furthermore, we could show an
interface dependent, spontaneous cross-link within hetero-
meric P2X1/2Rs. In contrast, dimerization between the cor-
responding P2X3 and P2X4 mutants was clearly less
eYcient but was somewhat increased by treatment with a
cysteine-speciWc cross-linker.
EYcient heteromerization between P2X1 
and P2X2 subunits
Of the 13 biochemically identiWed P2XR heteromers, only
7 have also been functionally deWned (for reviews see
North 2002; Nicke and King 2006; Guo et al. 2007).
Evidence for heteromerization between P2X1 and P2X2
subunits was obtained biochemically by co-immunoprecip-
itation (Torres et al. 1999) and BN-PAGE analysis
(AschraW et al. 2004). A carefully conducted study by
Brown et al. (2002) made use of the discriminating eVects
of extracellular pH to reveal functional evidence for a
P2X1/2 heteromer. Upon co-expression of P2X1 and P2X2
subunits in Xenopus oocytes, they described a current with
similar agonist sensitivity and kinetics as homomeric
P2X1R. But in contrast to homomeric P2X1Rs, the
responses of the P2X1/2 heteromer were increased at both
acidic and alkaline pH and showed an overt potentiation at
pH 5.5 (Brown et al. 2002). Although these data conWrm
the presence of a P2X1/2 heteromer with distinct functional
properties, they contrasted somewhat with independent bio-
chemical data (AschraW et al. 2004) because hetero-oligo-
merization was ineYcient and not seen in every oocyte,
which hampered further pharmacological characterization.
With our biochemical approach we were able to quantify
the dimer formation and show evidence for an eYcient but
not preferential assembly of these subunits. Reduction of
the cross-linked heteromer by DTT further allowed us to
speciWcally activate and characterize the heteromer cur-
rents. Although it has to be considered that we investigate
assumed binding site mutants, our data conWrm the Wndings
of Brown et al. that the P2X1/P2X2 heteromer displays
Table 1 Average receptor currents and desensitization time constants for P2X1K68C, P2X2F289C and heteromeric P2X1K68C/P2X2F289C
receptors with and without DTT incubation for 15 min (§SE, N = 5–7)
Receptor currents were activated by application of 300 M ATP at ¡60 mV
N.d. Not determined
Control +DTT
RNA ng/cell I (A) 1 (s) 2 (s) I (A) 1 (s) 2 (s)
P2X1K68C 21 8 § 0.3 3.8 § 0.3 13.5 § 0.6 19.4 § 2.4 4.2 § 0.5 11.2 § 1.5
P2X2F289C 3.5 5.6 § 0.5 N.d. N.d. 8.1 § 0.6 N.d. N.d.
P2X1K68C/P2X2F289C 21/3.5 2.85 § 0.11 N.d. N.d. 6.5 § 0.5 2.6 § 0.1 8.0 § 0.2123
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Furthermore, activation of heteromeric responses could be
quantitatively reproduced in every oocyte studied (see
Fig. 3f). Thus, similar approaches might be valuable for
functionally characterizing P2X heteromers that show only
subtle diVerences to the homomeric receptors.
Cross-linking eYciency
The eYcient cross-linking in P2X1 homomers (Marquez-
Klaka et al. 2007), P2X2 homomers and P2X1/2 heteromers
is in agreement with a conserved distance of the mutated
residues and supports the idea that their direct or indirect
interaction and/or distance is critical for receptor function,
as for example ligand binding. The strongly reduced
eYciency of cross-linking seen with homomeric P2X3 and
P2X4 receptors, even when using bifunctional cross-linkers,
might, however, indicate a larger distance at these inter-
faces and/or a variable orientation of the respective resi-
dues. Such diversity could account for pharmacological
diVerences between P2X subtypes. However, the fact that
both P2X1Rs and P2X3Rs show a quite similar pharmacol-
ogy (e. g. high sensitivity to ATP and TNP-ATP) while
P2X2Rs more closely resemble P2X4Rs in their lower sen-
sitivity for agonists and antagonists makes this assumption
less likely.
Another explanation for ineYcient or absent cross-link-
ing would be that diVerences in the time course of expres-
sion shifts the available ratio of mutant subunits against
eVective assembly and/or that diVerent time courses of sur-
face transport impair the appearance of cross-linked recep-
tors in the plasma membrane. The latter has also been
accounted for the slightly lower cross-linking eYciency of
plasma membrane bound P2X1 mutants in comparison to
the total P2X1 protein (Marquez-Klaka et al. 2007). Assum-
ing (1) complete chemical reaction, (2) purely stochastic
assembly (75% heteromer) and (3) equally eVective plasma
membrane transport of both mutants, the maximum amount
of cross-linked product is 50% (2/3 of the receptor subunits
are cross-linked, Fig. 1d, Marquez-Klaka et al. 2007). Rela-
tively minor shifts in the ratio of correctly synthesized
mutants and preferential surface transport of one of two
mutants can therefore already account for a clearly reduced
dimer fraction in membrane bound receptors (Fig. 1d). In
case of heteromeric receptors, this is further inXuenced by
the heteromerization eYciency and a possible preferential
stoichiometry.
Conservation of the binding site and role of the 
phenylalanine in the NFR motif in receptor function
The poor cross-linking in P2X3 and P2X4 subtypes might
also imply that one or both of the substituted residues do
not contribute to the formation of a conserved ATP-binding
pocket but might in fact have diVerent functions in receptor
activation. So far, most evidence for a direct involvement in
ATP binding exists for the K68 residue. Alanine mutations
of this residue in P2X1, P2X2, P2X3 and P2X4 subunits
resulted in functionally impaired or non-responsive recep-
tors (Wilkinson et al. 2006; Ennion et al. 2000; Jiang et al.
2000; Zemkova et al. 2007). Most convincing support for a
ligand binding function of this residue has been demon-
strated by single channel analysis of the K69A mutation in
the background of a constitutively active P2X2T339S
mutant (Cao et al. 2007).
On the contrary, the function of the F291 residue is still
less clear. A contribution to the coordination of ATP has
originally been suggested, based on a 160-fold shift in the
EC50 value for ATP upon mutation into alanine in P2X1
(Roberts and Evans 2004) while the EC50 was only shifted
10-fold in a study on the analogous P2X4F294A mutant
(Zemkova et al. 2007). A study in which P2X1 subunits
with cysteine-substituted N290, F291, R292, or K309 resi-
dues were treated with MTS reagents or the photoaYnity
label [32P] 2-Azido ATP supports the idea that these resi-
dues are involved in agonist binding (Roberts and Evans
2007). In agreement with our hypothesis that K68 and F291
lie on opposite sites of an intersubunit binding site, a contri-
bution of K68 and K309 from neighbouring subunits to
ATP function has also been proposed (Wilkinson et al.
2006; Marquez-Klaka et al. 2007). However, evidence for a
function of residues analogous to P2X1K309 and a nearby
segment involving G316 to I333 (in P2X4) in channel
gating rather than ligand binding is also accumulating
(Cao et al. 2007; Yan et al. 2006).
An intersubunit binding site is reminiscent of the
nAChRs. Another intriguing similarity between P2XRs
and nAChRs has been proposed by Adriouch et al. (2008).
Based on a study identifying ADP-ribosylation of R125 in
P2X7, these authors suggested that the cysteine-rich
domain formed by the Wrst six conserved cysteine residues
in P2X receptors might function as a “Wnger-like” struc-
ture which covers the ligand binding site. This would be
reminiscent of the C-loop in nAChRs. A cysteine-rich
“thumb” domain has also been identiWed in the ASIC
channel and is supposed to couple the binding of protons
to the opening of the ion channel. The proton-binding site
is thought to be located in a highly negatively charged cav-
ity formed by acidic amino acid residues from adjacent
subunits (Jasti et al. 2007). An attractive explanation for
the variable distance of residues analogous to K68 and
F291 would be that only K68 makes a direct contact with
ATP while F291 is situated on a more Xexible domain that
moves towards the binding site upon agonist binding, or
that the domains containing K68 and F291 both undergo
signiWcant movements relative to each other and that their123
Eur Biophys J (2009) 38:329–338 337distance depends on the receptor subtype and/or state of
the receptor.
DisulWde speciWc cross-linking and signiWcance for binding 
site/structure determination
In the current study, a speciWc cysteine cross-linking was
achieved with and without the addition of cross-linker in
the presence of ten or more endogenous cysteines. So far,
two other intersubunit cross-links between substituted cys-
teine residues have been identiWed.
In P2X2, P2X3 and P2X2/3 receptors, the substitution of
analogous valine and isoleucine residues located close to the
extracellular side of the Wrst and second TM, respectively,
resulted in dimer formation and a loss of function that could
be recovered by treatment with DTT (Spelta et al. 2003;
Jiang et al. 2003). These experiments showed a “head to
tail” orientation of the P2X subunits in the trimeric complex
and provided evidence for a 2:1 stoichiometry of PX3 and
P2X2 subunits in the heteromeric complex. The correspond-
ing interface was also preserved in P2X1Rs. Likewise, sub-
stitution of two histidine residues (H120C and H213C) in
the extracellular domain of the P2X2R lead to spontaneous
dimer formation and non-functional receptors that were acti-
vated by reduction of the disulWde bond (Nagaya et al.
2005). As these two residues have been shown to be impor-
tant for the modulatory action of Zn2+ at the P2X2R, an
inter-subunit Zn2+ binding site was concluded. Interestingly,
the modulatory Zn2+ binding site in two members of the
nAChR family, the glycine receptor and the -aminobutyric
acid type A receptor, has also been located at the interface of
two neighbouring subunits while both the agonist binding
site and the allosteric Zn2+ binding site of the GluR are
formed within a single subunit (Nagaya et al. 2005).
In the absence of high-resolution structural information,
these cross-linking data contribute to the understanding of
the subunit arrangement, heteromerization and stoichiome-
try as well as the relative localization of functionally impor-
tant residues. Independent of the speciWc function of the
substituted residues, they further help in mapping subunit
interfaces and identifying regions that move relative to each
other during channel activation. Together, this information
will help the interpretation of structures and the generation
of homology models for P2X subtypes once a high resolu-
tion P2XR structure becomes available.
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